Israel Active

The Council for Higher Education in Israel has granted approval to the independent Reichman University in Herzliya to establish a Medical School.  Eighty medical students will be enrolled in the first four-year program, which will begin in February 2025.

Israel’s Insightec has received both FDA approval and the CE mark for its Exablate Prime focused ultrasound system integrated with MR scanners from medical equipment giant Philips. It extends Insightec’s treatment of essential tremor and Parkinson's patients.

Video animation on how the spine implant from Israel’s Discure Technologies (see previously) restores the natural pumping function of a damaged disc to cure back pain.

Israel’s Converge Bio (see previously) builds large language models (LLMs) that accelerate the research process and remove much of the guesswork for biotech companies. It’s like ChatGPT for therapy development. It saves the trial and error, cost and time to develop new therapies.

Two doctors from Jerusalem’s Hadassah Medical organization have been awarded a grant from the Breast Cancer Research Foundation. Dr. Shani Paluch-Shimon and Dr. Michal Braun will study the varying cancer treatment outcomes with the diverse populations in Israel.

For easy general queries, chatbots can usually answer most medical queries. But for doctors wishing to diagnose and treat life-threatening conditions, they are not effective. Scientists at Israel’s Ben Gurion University have devised a questionnaire for comparing AI software.

Israel’s Droxi (see previously) has developed a software platform to help doctors manage administrative burdens. The idea for Droxi came after a medical error that harmed co-founder CEO Gadi Shenhar’s grandmother. Both co-founders are graduates of the elite IDF 8200 unit and the Technion.

Scientists at Israel’s Technion Institute have studied how RNA creates genes that make proteins. One process utilizes an enzyme called ADAR, which sometimes creates a genetic mutation that leads to cancer or brain disease. The discovery could result in a gene repair process and disease eradication.

Israel’s Biolojic Design (see previously) is joining the Johnson & Johnson Innovation – JLABS (JLABS) to develop therapeutic antibodies at its Washington, D.C. site. JLABS is one of the largest global networks of incubators pioneering groundbreaking healthcare solutions.

Israel’s Momentis Surgical (see previously) now has US FDA approval for its 2nd-generation Anovo® robotic surgical platform. The new version has haptic feedback, allowing the surgeon to “feel” what he is doing. Also, new video and annotation features help communication and training.